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Abstracts / Osteoarthritis and Cartilage 21 (2013) S63–S312 S65Results: A single application of cyclic compressive loading of 3, 6 and 9
N produced increasing severity of articular cartilage lesions associated
with secondary responses in other joint tissues. All loading regiments
induced loss of Safranin O staining, cartilage matrix damage, disruption
of collagen ﬁbril arrangement, and chondrocyte apoptosis at all time
points, localized to the articular cartilage of the lateral posterior femoral
condyle. Six N loading induced mild synovitis by day 5. Nine N loading
lead to anterior cruciate ligament tearing, severe posttraumatic syno-
vitis and ectopic cartilage formation. At 9 days after 9N loading,
aggrecan and cartilage oligomeric matrix protein were extensively
detected in synovia, while at 14 days those matrix proteins limited the
distribution in local synovia and co-localized with newly synthesized
type II collagen. At 14 days following all injuries, type I collagen was
detected in the impacted region of cartilage indicating inappropriate
repair of the cartilage matrix.
Conclusions: We established and validated a murine model of knee
joint trauma with different degrees of over-loading in vivo. The early
events that followed joint trauma were dose dependent and indi-
cated that cartilage has a very limited capacity for self-repair. At the
highest loading level (9N), with rupture of the ACL, extensive
changes were seen including extensive synovitis and neo-cartilage
formation. These results suggest that immediate therapies particu-
larly targeted to apoptosis and synovial proliferation could affect the
acute posttraumatic reaction to ultimately limit chronic conse-
quences and potentially osteoarthritis.Ă
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OSTEOARTHRITIS DEVELOPMENT IS INDUCED BY INCREASED
DIETARY CHOLESTEROL IN APOE*3LEIDEN.CETP MICE,
A TRANSLATIONAL MODEL FOR ATHEROSCLEROSIS, AND CAN BE
INHIBITED BY ATORVASTATINFigure 1. (A) Sum of OA grades on the medial side of the knee joint, (B) Lesion area
(atherosclerosis) and C correlation between sum OA grades medial and cholesterol
exposure(R¼0.4, p¼0.02). *p<0.05 ***p<0.001 vs HC, #p<0.05, ###p<0.001 vs Control.
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Purpose:Hypercholesterolemia, a risk factor foratherosclerosis (ATH)has
been suggested tohave a role in thedevelopmentof osteoarthritis (OA). To
test thishypothesis, theeffectof increasingcholesterol levels anddifferent
cholesterol-lowering treatments on the development of OA was investi-
gated in a mouse model resembling human lipoprotein metabolism.
Methods: Female ApolipoproteinE*3Leiden.human Cholesteryl Ester
Transfer Protein (APOE*3LeidenCETP) transgenic mice (10-16 wks,
n¼12/group) received a western type diet (WTD). This diet was sup-
plemented with 0.1% (w/w) cholesterol (LC), 0.3% (w/w) cholesterol
alone (HC) (n¼12) or HC with 3 mg/kg/day of the HMG-CoA reductase
inhibitor atorvastatin (HC atorvastatin) or 0.3 mg/kg/day of the
cholesterol absorption inhibitor ezetimibe (HC ezetimibe). One group
remained on chow (control). After 39 weeks of intervention, mice were
sacriﬁced and OA grades in the knee and atherosclerosis size and
composition in the aortic origin were assessed. Plasma cholesterol
levels were measured throughout the study.
Results:Mice receiving LC and HC had signiﬁcantly more OA features at
the medial side of the knee joint compared to control mice. OA features
were signiﬁcantly suppressed by atorvastatin but not by ezetimibe. No
effects of increased intake of cholesterol were seen on the lateral side or
the patella. HC groups developed signiﬁcantly more atherosclerosis
which was suppressed to a similar extent by atorvastatin and ezetimibe
(48% and 55% respectively). A signiﬁcant mild association between the
development of OA on the medial side and cholesterol exposure or
atherosclerosis development was found (both R¼0.4, p<0.05).
Conclusions: Dietary cholesterol and consequently increased plasma
cholesterol levels play a role in the development of OA. The moderate
correlation betweenOA and cholesterol exposure in thesemice suggests
that atherosclerosis and osteoarthritis are associated through common
underlying mechanisms, but that processes independent of cholesterol
exposure contribute to the development of OA features as well. This is
further substantiated by the difference in effect of atorvastatin and
ezetimibe. Although both drugs reduced cholesterol levels to the same
extent, only atorvastatin signiﬁcantly diminished OA severity, ruling out
cholesterol exposure as single factor in OA development.Fig. 1. A) Genes differentially expressed in the VLDmodel and human OA (Aigner, 2007;
Karlsson, 2010), B) Venn diagram illustrating load-induced differential expression (100%
vs. 0%BW) at 6 and 20 wks; and select genes with increased ([) and decreased (Y)
expression. C) Fold changes of genes differentially expressed in the VLDmodel at 20wks
(x-axis) in common with those expressed in human OA (y-axis) illustrating that the
majority of common genes trended in the same direction (shaded quadrants).105
GLOBAL ANALYSIS OF CHONDROCYTE GENE EXPRESSION IN LOAD-
INDUCED CARTILAGE DEGENERATION IN THE RAT
M.L. Roemhildt, A.E. Gauthier. Univ. of Vermont, Burlington, VT, USA
Purpose: This study 1) investigated time-dependent changes in chon-
drocyte gene expression in response to increased chronic in vivo loading
of the rat tibiofemoral joint to identify molecular pathways regulating
response to loading and early joint degeneration; and 2) compared the
genetic response of our animal model to that in human OA.
Methods: NIH guidelines for the use of animals were observed. Twenty
mature male Sprague-Dawley rats were randomized into 4 groups: 0%-
6wk, 0%-20wk, 100%-6wk, and 100%-20wk. A varus loading device
(VLD) surgically attached to the hind limb of the rat applied an overload
of 0% or 100% body weight to the medial compartment of the knee 24
hr/day for 6 or 20 weeks. Loads were in addition to normally occurring
joint forces. Microarray analysis was performed (Affymetrix Rat
GeneArray 1.0 ST representing 27,342 genes) on individual RNA samples
extracted from articular cartilage of medial femoral condyles. Total RNA
was ampliﬁed, hybridized, and scanned. After bioinformatics processing
of raw data, linear models were evaluated using ANOVA-derived
expression statistics. Candidate genes for pathway analysis were
selected as those exhibiting a p-value  .05 and jfold-changej  1.2
between groups. Immunohistochemistry (IHC) validated select genes
dysregulated in our analysis. DAVID Bioinformatics Resources identiﬁed
sets of genes and their associated biological pathways that were over-
represented with increased load. The genetic response of the rat VLD
model was compared to that of human OA by comparing differentially
expressed transcripts to orthologs in 2 reported human studies.
Results: Increased loading resulted in differential expression of 634
transcripts at 6 weeks and 898 transcripts at 20 weeks (Fig1A). DAVID
